LONDON--(BUSINESS WIRE)--RepRegenTM Ltd the ‘smart biomaterials’ company, announced today that it has raised £1.03 million ($1.6 million). The financing was led by existing investor Imperial Innovations and included Longbow Capital and other investors. Proceeds will be used to further the product development pipeline: including regulatory approvals, commercialization programs and preparation for relevant post market clinical studies.
